Pubblicazioni Scientifiche

Dermatologia

03 ott 2022

Dupilumab in children aged 6 months to younger than 6 years

Background Current systemic treatments for children younger than 6 years with moderate-to-severe atopic dermatitis

03 ott 2022

FDA approves Ruxolitinib

The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura)

28 set 2022

The role of HPV in keratinocyte skin cancer development

Keratinocyte skin cancers are the most frequent malignancy, accounting for approximately 30% of all cancers

28 set 2022

Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas

Brentuximab vedotin (BV) has been approved for CD30-expressing cutaneous T-cell lymphoma

28 set 2022

Atopic dermatitis and risk of major neuropsychiatric disorders in children

Paediatric atopic dermatitis (AD) has been linked to neuropsychiatric comorbidities

19 set 2022

Eczema European guideline part II

The evidence- and consensus-based guideline on atopic eczema

19 set 2022

Eczema European guideline part I

The evidence-and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline

19 set 2022

Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities

Cutaneous immune-related adverse events (irAEs) represent the most frequent toxicities

15 set 2022

Efficacy of dupilumab in chronic prurigo and chronic idiopathic pruritus

Dupilumab has demonstrated a great reduction in chronic pruritus that is the hallmark of atopic dermatitis

15 set 2022

Assessing changes in facial skin quality using

Studies utilizing reflectance confocal microscopy (RCM) and dynamic optical coherence tomography

15 set 2022

Dermoscopy of cutaneous adnexal tumours a systematic review

Cutaneous adnexal tumours (ATs) encompass a variegated group of hamartomas and benign or malignant tumours

05 set 2022

Curettage vs. cryosurgery for superficial basal cell carcinoma

Basal cell carcinoma (BCC) is the most common cancer in the world and has a rising incidence.

05 set 2022

Guidelines for narrowband ultraviolet B phototherapy 2022

British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022

05 set 2022

Updated S2K guidelines on the management of pemphigus vulgaris

Pemphigus encompasses a group of life-threatening autoimmune bullous diseases characterized

01 ago 2022

Rosacea, an infectious disease

Rosacea and demodicosis are common facial conditions in dermatology practice

01 ago 2022

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

Since the second version of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

01 ago 2022

Adult atopic eczema and the risk of dementia

Chronic inflammatory conditions have been linked to dementia, but little is known about the role of atopic eczema

27 lug 2022

Monkeypox emerges on a global scale

The current monkeypox outbreak reawakens the concern that poxviridae have high potential of zoonotic spillover and for causing pandemic

27 lug 2022

New insights from non-invasive imaging

The incidence of non-melanoma skin cancer is on the rise and melanoma is among the most common cancers in the United States.

27 lug 2022

Infection risk in psoriatic patients receiving tumour necrosis factor inhibitors

Tumour necrosis factor inhibitors (TNFis) are commonly used for treating psoriatic diseases; however, the risk of infection while receiving TNFis remains uncertain